Trending Now
Manchester Arena Attack Survivors Lack Support, Study Finds
While 93% of young survivors felt they needed support in the aftermath of the attack, 70% received no professional help within the first month and 31% received no professional help within the first year.
FDA Announces Additional Steps to Modernize Clinical Trials
The COVID-19 pandemic highlighted many of these challenges, while also spurring the development of new approaches.
DHS S&T Tech Speak: Understanding What Responders Need
Hear from subject matter experts, industry, and responders themselves as they discuss the challenges (and solutions) for getting the respiratory protection today’s wildland firefighters desperately need.
HSToday Interview: The UNHACKABLE INTERNET with Thomas Vartanian
If you knew a coming attack would disarm national security, wipe out the electric grid, destroy banking networks, and cause your money to disappear,...
LATEST ARTICLES
PERSPECTIVE: The Need for a Comprehensive Strategy Addressing Cybersecurity and Quantum...
A true strategy that comprehensively addresses QIS, cybersecurity, artificial intelligence, and other groundbreaking technologies is missing from our arsenal of capabilities.
Joint Guide to Securing Remote Access Software Released by CISA and...
All organizations are encouraged to review the joint guide and implement recommended mitigations and best practices.
OIG Finds Access Security Weaknesses at the Department of Transportation
Personal Identity Verification cards are issued to contractor employees, granting them access to secure, and sometimes sensitive, DOT facilities and information technology systems.
DHS’s Blue Campaign Releases Human Trafficking Awareness Toolkit for Tribal Gaming...
Created at the request of, and with input from, tribal leaders, tribal gaming employees, and indigenous communities, this toolkit provides culturally appropriate, survivor-informed tips and resources.
Delaware CBP Officers Seize Opium Poppy Pod Shipment Destined for Dover
Opium abuse may lead to severe physical and psychological dependence and can lead to an overdose.
FDA Announces Additional Steps to Modernize Clinical Trials
The COVID-19 pandemic highlighted many of these challenges, while also spurring the development of new approaches.